Through its affiliated development entities, global R&D network, and GMP-grade investigational product manufacturing capabilities, LUTERION is positioned to support translational research, nonclinical development, clinical coordination, and therapeutic development across multiple disease areas.
Collaboration around the Lu120819 platform spanning translational research and development strategy.
Co-development opportunities supported by the group's global R&D and manufacturing network.
Indication-specific partnerships across selected therapeutic areas advanced with affiliated development entities.